294 related articles for article (PubMed ID: 16602100)
21. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular investigation in Chinese patients with glutaric aciduria type I.
Zhang Y; Li H; Ma R; Mei L; Wei X; Liang D; Wu L
Clin Chim Acta; 2016 Jan; 453():75-9. PubMed ID: 26656312
[TBL] [Abstract][Full Text] [Related]
23. Glutaric acidemia type I: a neurosurgical perspective. Report of two cases.
Hou LC; Veeravagu A; Hsu AR; Enns GM; Huhn SL
J Neurosurg; 2007 Aug; 107(2 Suppl):167-72. PubMed ID: 18459892
[TBL] [Abstract][Full Text] [Related]
24. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
[TBL] [Abstract][Full Text] [Related]
25. A role of astrocytes in mediating postnatal neurodegeneration in Glutaric acidemia-type 1.
Olivera-Bravo S; Barbeito L
FEBS Lett; 2015 Nov; 589(22):3492-7. PubMed ID: 26409499
[TBL] [Abstract][Full Text] [Related]
26. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
[TBL] [Abstract][Full Text] [Related]
27. A treatable neurometabolic disorder: glutaric aciduria type 1.
Pusti S; Das N; Nayek K; Biswas S
Case Rep Pediatr; 2014; 2014():256356. PubMed ID: 24587932
[TBL] [Abstract][Full Text] [Related]
28. Impairment of astrocytic glutaminolysis in glutaric aciduria type I.
Komatsuzaki S; Ediga RD; Okun JG; Kölker S; Sauer SW
J Inherit Metab Dis; 2018 Jan; 41(1):91-99. PubMed ID: 29098534
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of glutaric aciduria type I--revised recommendations.
Kölker S; Christensen E; Leonard JV; Greenberg CR; Boneh A; Burlina AB; Burlina AP; Dixon M; Duran M; García Cazorla A; Goodman SI; Koeller DM; Kyllerman M; Mühlhausen C; Müller E; Okun JG; Wilcken B; Hoffmann GF; Burgard P
J Inherit Metab Dis; 2011 Jun; 34(3):677-94. PubMed ID: 21431622
[TBL] [Abstract][Full Text] [Related]
30. Renal insufficiency mimicking glutaric acidemia type 1 on newborn screening.
Matsumoto M; Awano H; Bo R; Nagai M; Tomioka K; Nishiyama M; Ninchouji T; Nagase H; Yagi M; Morioka I; Hasegawa Y; Takeshima Y; Iijima K
Pediatr Int; 2018 Jan; 60(1):67-69. PubMed ID: 29059480
[TBL] [Abstract][Full Text] [Related]
31. An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1.
Goodman SI; Woontner M
Mol Genet Metab; 2019 Aug; 127(4):325-326. PubMed ID: 31324527
[No Abstract] [Full Text] [Related]
32. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
[TBL] [Abstract][Full Text] [Related]
33. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort.
Funk CB; Prasad AN; Frosk P; Sauer S; Kölker S; Greenberg CR; Del Bigio MR
Brain; 2005 Apr; 128(Pt 4):711-22. PubMed ID: 15689364
[TBL] [Abstract][Full Text] [Related]
34. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations.
Kyllerman M; Skjeldal OH; Lundberg M; Holme I; Jellum E; von Döbeln U; Fossen A; Carlsson G
Mov Disord; 1994 Jan; 9(1):22-30. PubMed ID: 8139602
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic evaluation of glutaric acidemia type 1 by an in vitro probe assay of acylcarnitine profiling using fibroblasts and electrospray ionization/tandem mass spectrometry (MS/MS).
Mushimoto Y; Hasegawa Y; Kobayashi H; Li H; Purevsuren J; Nakamura I; Taketani T; Fukuda S; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2648-51. PubMed ID: 19467937
[TBL] [Abstract][Full Text] [Related]
36. [Mass spectrometry combined with gene analysis for prenatal diagnosis of glutaric acidemia type Ⅰ].
Han F; Han LS; Ji WJ; Chen T; Xu F; Wang Y; Ye J; Qiu WJ; Zhang HW; Jiang YZ; Hou C; Gu XF
Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):539-543. PubMed ID: 28728265
[No Abstract] [Full Text] [Related]
37. [Development of brain atrophy, therapy and therapy monitoring in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)].
Lawrenz-Wolf B; Herberg KP; Hoffmann GF; Hunneman DH; Lehnert W; Hanefeld F
Klin Padiatr; 1993; 205(1):23-9. PubMed ID: 8445849
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of brain damage in glutaric acidemia type I: Lessons from the genetic mice model.
Wajner M; Amaral AU; Leipnitz G; Seminotti B
Int J Dev Neurosci; 2019 Nov; 78():215-221. PubMed ID: 31125684
[TBL] [Abstract][Full Text] [Related]
39. [Macrocephaly and dystonic cerebral palsy in a child with type I glutaric aciduria].
Plöchl E; Christensen E; Colombo JP; Weiss-Wichert P; Wenger E
Padiatr Padol; 1991; 26(2):97-101. PubMed ID: 1945471
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
